Association study of GIT1 gene with attention‐deficit hyperactivity disorder in Brazilian children and adolescents
暂无分享,去创建一个
L A Rohde | L. Rohde | C. Zeni | G. Polanczyk | T. Román | G Polanczyk | J. Genro | M. Schmitz | M H Hutz | A Salatino-Oliveira | J P Genro | R Chazan | C Zeni | M Schmitz | T Roman | A. Salatino‐Oliveira | M. Hutz | R. Chazan
[1] R. Lefkowitz,et al. Multiple endocytic pathways of G protein-coupled receptors delineated by GIT1 sensitivity. , 2000, Proceedings of the National Academy of Sciences of the United States of America.
[2] B. Franke,et al. Integrated genome-wide association study findings: identification of a neurodevelopmental network for attention deficit hyperactivity disorder. , 2011, The American journal of psychiatry.
[3] Marianne van den Bree,et al. Predictors of antisocial behaviour in children with attention deficit hyperactivity disorder , 2006, European Child & Adolescent Psychiatry.
[4] L. Rohde,et al. Attention-deficit hyperactivity disorder: a study of association with both the dopamine transporter gene and the dopamine D4 receptor gene. , 2001, American journal of medical genetics.
[5] L. DeLisi,et al. When is a “Positive” association truly a “Positive” in psychiatric genetics? A commentary based on issues debated at the World Congress of Psychiatric Genetics, Boston, October 12–18, 2005 , 2006, American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics.
[6] Lorena Za,et al. ADP-ribosylation factor 6 and a functional PIX/p95-APP1 complex are required for Rac1B-mediated neurite outgrowth. , 2003, Molecular biology of the cell.
[7] I. Rudan,et al. Interpretation of genetic association studies in complex disease , 2002, The Pharmacogenomics Journal.
[8] Eunjoon Kim,et al. GIT1 is associated with ADHD in humans and ADHD-like behaviors in mice , 2011, Nature Medicine.
[9] H. Orvaschel. Psychiatric interviews suitable for use in research with children and adolescents. , 1985, Psychopharmacology bulletin.
[10] L. Rohde,et al. Smoking during pregnancy and attention-deficit/hyperactivity disorder, predominantly inattentive type: a case-control study. , 2006, Journal of the American Academy of Child and Adolescent Psychiatry.
[11] R. Lefkowitz,et al. beta2-Adrenergic receptor regulation by GIT1, a G protein-coupled receptor kinase-associated ADP ribosylation factor GTPase-activating protein. , 1998, Proceedings of the National Academy of Sciences of the United States of America.
[12] D. Balding. A tutorial on statistical methods for population association studies , 2006, Nature Reviews Genetics.
[13] R. Deane,et al. Impaired spine formation and learning in GPCR kinase 2 interacting protein-1 (GIT1) knockout mice , 2010, Brain Research.
[14] Alcino J. Silva,et al. Modeling hyperactivity: of mice and men , 2011, Nature Medicine.
[15] B. Berk,et al. The multifunctional GIT family of proteins , 2006, Journal of Cell Science.
[16] N. Freimer,et al. Geographic Patterns of Genome Admixture in Latin American Mestizos , 2008, PLoS genetics.
[17] S. Faraone,et al. Meta-Analysis of Structural Imaging Findings in Attention-Deficit/Hyperactivity Disorder , 2007, Biological Psychiatry.
[18] K. Lange,et al. Animal models of attention deficit/hyperactivity disorder (ADHD): a critical review , 2010, Attention deficit and hyperactivity disorders.
[19] C. Kieling,et al. Attention-deficit/hyperactivity disorder and the dopaminergic hypotheses , 2010, Expert review of neurotherapeutics.
[20] J. Hirschhorn,et al. A comprehensive review of genetic association studies , 2002, Genetics in Medicine.
[21] T. Shaikh,et al. Rare structural variants found in attention-deficit hyperactivity disorder are preferentially associated with neurodevelopmental genes , 2010, Molecular Psychiatry.
[22] B. Horta,et al. The worldwide prevalence of ADHD: a systematic review and metaregression analysis. , 2007, The American journal of psychiatry.
[23] Elizabeth B. Owens,et al. Clinical relevance of the primary findings of the MTA: success rates based on severity of ADHD and ODD symptoms at the end of treatment. , 2001, Journal of the American Academy of Child and Adolescent Psychiatry.
[24] J. Swanson,et al. Evaluating dopamine reward pathway in ADHD: clinical implications. , 2009, JAMA.
[25] S. Mostofsky,et al. Abnormal cerebral cortex structure in children with ADHD , 2009, Human brain mapping.
[26] R. Rodriguiz,et al. Impaired fear response in mice lacking GIT1 , 2009, Neuroscience Letters.
[27] Edgar Erdfelder,et al. GPOWER: A general power analysis program , 1996 .
[28] Xin Xu,et al. Implementing a unified approach to family‐based tests of association , 2000, Genetic epidemiology.